Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning
An improved approach for predicting the risk for incident coronary heart disease (CHD) could lead to substantial improvements in cardiovascular health. Previously, we have shown that genetic and epigenetic loci could predict CHD status more sensitively than conventional risk factors. Herein, we exam...
Main Authors: | Meeshanthini V. Dogan, Steven R. H. Beach, Ronald L. Simons, Amaury Lendasse, Brandan Penaluna, Robert A. Philibert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/9/12/641 |
Similar Items
-
The Reversion of DNA Methylation at Coronary Heart Disease Risk Loci in Response to Prevention Therapy
by: Willem Philibert, et al.
Published: (2021-04-01) -
A Direct Comparison of the Relationship of Epigenetic Aging and Epigenetic Substance Consumption Markers to Mortality in the Framingham Heart Study
by: James A. Mills, et al.
Published: (2019-01-01) -
Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study.
by: Meeshanthini V Dogan, et al.
Published: (2018-01-01) -
Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey
by: Hye Mi Kang, et al.
Published: (2012-06-01) -
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
by: Natasha A. Jain, et al.
Published: (2020-06-01)